Cargando…

Acute Regression in Down Syndrome

Background: Acute regression has been reported in some individuals with Down syndrome (DS), typically occurring between the teenage years and mid to late 20s. Characterized by sudden, and often unexplained, reductions in language skills, functional living skills and reduced psychomotor activity, som...

Descripción completa

Detalles Bibliográficos
Autores principales:	Handen, Benjamin, Clare, Isabel, Laymon, Charles, Petersen, Melissa, Zaman, Shahid, O’Bryant, Sid, Minhas, Davneet, Tudorascu, Dana, Brown, Stephanie, Christian, Bradley
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391552/ https://www.ncbi.nlm.nih.gov/pubmed/34439728 http://dx.doi.org/10.3390/brainsci11081109

Ejemplares similares

Amyloid accumulation in Down syndrome measured with amyloid load
por: Zammit, Matthew D., et al.
Publicado: (2020)

Cognitive indicators of transition to preclinical and prodromal stages of Alzheimer's disease in Down syndrome
por: Hartley, Sigan L., et al.
Publicado: (2020)

Statistical Methods for Processing Neuroimaging Data from Two Different Sites with a Down Syndrome Population Application
por: Minhas, Davneet S., et al.
Publicado: (2020)

Role of tau deposition in early cognitive decline in Down syndrome
por: Hartley, Sigan L., et al.
Publicado: (2022)

Timing of Alzheimer’s Disease by Intellectual Disability Level in Down Syndrome
por: Hartley, Sigan L., et al.
Publicado: (2023)

White matter microstructure associations with episodic memory in adults with Down syndrome: a tract-based spatial statistics study
por: Bazydlo, Austin, et al.
Publicado: (2021)

The use of Centiloids for applying [(11)C]PiB classification cutoffs across region-of-interest delineation methods
por: Tudorascu, Dana L., et al.
Publicado: (2018)

Amyloid- β and tau deposition influences cognitive and functional decline in Down syndrome
por: Grigorova, Monika, et al.
Publicado: (2022)

Patterns of glucose hypometabolism in Down syndrome resemble sporadic Alzheimer's disease except for the putamen
por: Zammit, Matthew D., et al.
Publicado: (2021)

PET measurement of longitudinal amyloid load identifies the earliest stages of amyloid-beta accumulation during Alzheimer’s disease progression in Down syndrome
por: Zammit, Matthew D., et al.
Publicado: (2021)

Relationship of amyloid beta and neurofibrillary tau deposition in Neurodegeneration in Aging Down Syndrome (NiAD) study at baseline
por: Tudorascu, DL, et al.
Publicado: (2020)

Characterization of point-spread function specification error on Geometric Transfer Matrix partial volume correction in [(11)C]PiB amyloid imaging
por: Laymon, Charles M., et al.
Publicado: (2021)

Neurofibrillary tau depositions emerge with subthreshold cerebral beta-amyloidosis in down syndrome
por: Zammit, Matthew D., et al.
Publicado: (2021)

The Alzheimer's Biomarker Consortium‐Down Syndrome: Rationale and methodology
por: Handen, Benjamin L., et al.
Publicado: (2020)

White matter microstructure associations to amyloid burden in adults with Down syndrome
por: Bazydlo, Austin M., et al.
Publicado: (2021)

Proteomic profiles for Alzheimer's disease and mild cognitive impairment among adults with Down syndrome spanning serum and plasma: An Alzheimer's Biomarker Consortium–Down Syndrome (ABC–DS) study
por: Petersen, Melissa E., et al.
Publicado: (2020)

Detection of Brain Tau Pathology in Down Syndrome Using Plasma Biomarkers
por: Janelidze, Shorena, et al.
Publicado: (2022)

MISPEL: A supervised deep learning harmonization method for multi-scanner neuroimaging data
por: Torbati, Mahbaneh Eshaghzadeh, et al.
Publicado: (2023)

Support vector machine learning and diffusion-derived structural networks predict amyloid quantity and cognition in adults with Down’s syndrome
por: Brown, Stephanie S.G., et al.
Publicado: (2022)

Cortical atrophy and amyloid and tau deposition in Down syndrome: A longitudinal study
por: Padilla, Concepcion, et al.
Publicado: (2022)

Physical activity, memory function, and hippocampal volume in adults with Down syndrome
por: Peven, Jamie C., et al.
Publicado: (2022)

APOEε4 Genotype Is Related to Brain Amyloid Among Mexican Americans in the HABS-HD Study
por: O'Bryant, Sid E., et al.
Publicado: (2022)

A multi-scanner neuroimaging data harmonization using RAVEL and ComBat
por: Torbati, Mahbaneh Eshaghzadeh, et al.
Publicado: (2021)

Plasma Total Tau and Neurobehavioral Symptoms of Cognitive Decline in Cognitively Normal Older Adults
por: Hall, James R., et al.
Publicado: (2021)

Depression is differentially related to cognitive and biomarker outcomes among Mexican Americans
por: O’Bryant, Sid E., et al.
Publicado: (2022)

Characterizing Plasma Biomarkers of Alzheimer's in a Diverse Community-Based Cohort: A Cross-Sectional Study of the HAB-HD Cohort
por: Hall, James R., et al.
Publicado: (2022)

Proteomic profiles of prevalent mild cognitive impairment and Alzheimer's disease among adults with Down syndrome
por: Petersen, Melissa, et al.
Publicado: (2020)

Accelerating Hyperparameter Tuning in Machine Learning for Alzheimer’s Disease With High Performance Computing
por: Zhang, Fan, et al.
Publicado: (2021)

Combination of Serum and Plasma Biomarkers Could Improve Prediction Performance for Alzheimer’s Disease
por: Zhang, Fan, et al.
Publicado: (2022)

Hyperparameter Tuning with High Performance Computing Machine Learning for Imbalanced Alzheimer’s Disease Data
por: Zhang, Fan, et al.
Publicado: (2022)

Imaging neurodegeneration in Down syndrome: brain templates for amyloid burden and tissue segmentation
por: Lao, Patrick J., et al.
Publicado: (2018)

Introduction to special issue on Advances in blood-based biomarkers of Alzheimer's disease
por: O'Bryant, Sid E.
Publicado: (2016)

Impact of partial volume correction on the regional correspondence between in vivo [C-11]PiB PET and postmortem measures of Aβ load
por: Minhas, Davneet S., et al.
Publicado: (2018)

Associations between NIH Toolbox Cognition Battery and in vivo brain amyloid and tau pathology in non‐demented older adults
por: Snitz, Beth E., et al.
Publicado: (2020)

Parkinson’s Disease Blood Test for Primary Care
por: O’Bryant, Sid E., et al.
Publicado: (2022)

A Systematic Review of Unexplained Early Regression in Adolescents and Adults with Down Syndrome
por: Walpert, Madeleine, et al.
Publicado: (2021)

A Precision Medicine Approach to Treating Alzheimer’s Disease Using Rosiglitazone Therapy: A Biomarker Analysis of the REFLECT Trials
por: O’Bryant, Sid E., et al.
Publicado: (2021)

Molecular markers of neuropsychological functioning and Alzheimer's disease
por: Edwards, Melissa, et al.
Publicado: (2015)

Arsenic exposure, AS3MT polymorphism, and neuropsychological functioning among rural dwelling adults and elders: a cross-sectional study
por: Edwards, Melissa, et al.
Publicado: (2014)

Cerebrospinal fluid biomarkers of Alzheimer's disease in a cohort of adults with Down syndrome
por: Henson, Rachel L., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_69e81pae58gcilcpu3g9lh1bgn